Evidence map›Paper›PMID 36857178›Full record

ArticleCell reports2023

SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.

Fabricia L Fontes-Dantas, Gabriel G Fernandes, Elisa G Gutman, Emanuelle V De Lima, Leticia S Antonio, Mariana B Hammerle, Hannah P Mota-Araujo, Lilian C Colodeti, Suzana M B Araújo, Gabrielle M Froz and 15 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
34.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Neurodegenerative and Cognitive Consequences of Long COVID.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Palmitoylated COX-2Journal of advanced research · 2026
    Article
  18. Article
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 3 institutions in 1 country.

Fabricia L Fontes-DantasSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
Gabriel G FernandesSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Elisa G GutmanTranslational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Clinical Medicine Post-graduation Program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Emanuelle V De LimaSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Leticia S AntonioSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Mariana B HammerleClinical Medicine Post-graduation Program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Hannah P Mota-AraujoSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Lilian C ColodetiSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Suzana M B AraújoSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Gabrielle M FrozSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Talita N da SilvaSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Larissa A DuarteTranslational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Clinical Medicine Post-graduation Program, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Andreza L SalvioTranslational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil.
Karina L PiresNeurology Department, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, RJ, Brazil.
Luciane A A LeonLaboratório de Desenvolvimento Tecnológico em Virologia, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Claudia Cristina F VasconcelosNeurology Department, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, RJ, Brazil.
Luciana RomãoInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Luiz Eduardo B SavioInstitute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Jerson L SilvaInstitute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Robson da CostaSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Julia R ClarkeInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Andrea T Da PoianInstitute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: dapoian@bioqmed.ufrj.br.
Soniza V Alves-LeonTranslational Neuroscience Laboratory (LabNet), Post-Graduate Program in Neurology, Federal University of Rio de Janeiro State, Rio de Janeiro, RJ, Brazil; Division of Neurology, Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: sonizavieiraalvesleon@gmail.com.
Giselle F PassosSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: gfazzioni@yahoo.com.br.
Claudia P FigueiredoSchool of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: claudia@pharma.ufrj.br.
Universidade Federal do Rio de Janeiro · BRUniversidade Federal do Estado do Rio de Janeiro · BRFundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive dysfunction is often reported in patients with post-coronavirus disease 2019 (COVID-19) syndrome, but its underlying mechanisms are not completely understood. Evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike protein or its fragments are released from cells during infection, reaching different tissues, including the CNS, irrespective of the presence of the viral RNA. Here, we demonstrate that brain infusion of Spike protein in mice has a late impact on cognitive function, recapitulating post-COVID-19 syndrome. We also show that neuroinflammation and hippocampal microgliosis mediate Spike-induced memory dysfunction via complement-dependent engulfment of synapses. Genetic or pharmacological blockage of Toll-like receptor 4 (TLR4) signaling protects animals against synapse elimination and memory dysfunction induced by Spike brain infusion. Accordingly, in a cohort of 86 patients who recovered from mild COVID-19, the genotype GG TLR4-2604G>A (rs10759931) is associated with poor cognitive outcome. These results identify TLR4 as a key target to investigate the long-term cognitive dysfunction after COVID-19 infection in humans and rodents.

Indexed as

Cognitive DysfunctionCOVID-19AnimalsHumansMicePost-Acute COVID-19 SyndromeSARS-CoV-2Spike Glycoprotein, CoronavirusToll-Like Receptor 4Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2TLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4cognitive dysfunctionCP: ImmunologyCP: Neurosciencegenetic variantlong COVIDmicrogliosisneuroinflammationpost-COVID syndromeSARS-CoV-2 spike proteinsynapse losssynaptic pruningTLR4

Identifiers

PMID36857178
PMCPMC9935273
OpenAlexW4321254566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.